US Regulatory Roundup, October 2018: It Wasn't All Scary
Executive Summary
Troubling stories about US FDA inspections captured the attention of Medtech Insight readers last month. Other noteworthy US regulatory and policy themes from October: efforts to improve device reimbursement, salary trends, and a medtech focus in Congress.